Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706836 · ClinicalTrials.gov registry record · Phase 4
PharmacofMRI of Anxiolytic Medications (Pregabalin)
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT00706836 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 16 participants.
The verdict
NCT00706836, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to use functional magnetic resonance imaging (fMRI) in healthy controls to examine the acute effects of certain anxiolytic medications on brain function. In this case, the medication pregabalin will be used. The investigators hypothesize that pregabalin (at doses of 50 mg and 200 mg, versus placebo) will yield a reduction in amygdala and insula activity (in a dose-dependent fashion) during emotion processing using fMRI.
Interventions
- DRUG placebo
- DRUG Pregabalin 50mg
- DRUG Pregabalin 200 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00706836
The ClinicalTrials.gov registry entry for NCT00706836 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00706836 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00706836 about?
NCT00706836 is a clinical study titled "PharmacofMRI of Anxiolytic Medications (Pregabalin)". The purpose of this study is to use functional magnetic resonance imaging (fMRI) in healthy controls to examine the acute effects of certain anxiolytic medications on brain function. In this case, the medication pregabalin will be used. The investigators hypothesize that pregabalin (at doses of 50 m...
What is the current status of trial NCT00706836?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2008-06. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00706836?
The interventions under investigation include: placebo (DRUG), Pregabalin 50mg (DRUG), Pregabalin 200 MG (DRUG).
Who is sponsoring clinical trial NCT00706836?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.